Vaso-Occlusive Crises clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults

    open to eligible people ages 5-20

    The purpose of this research is to see if ketamine is effective and safe in treating children and young adults with sickle cell disease experiencing sickle cell related pain. In this study, we will compare the outcomes (such as pain scores) in persons who receive standard of care pain medicine (an opioid such as morphine) plus a low dose (amount) of ketamine to those who receive only standard of care pain medicine.

    at UCLA

Our lead scientists for Vaso-Occlusive Crises research studies include .

Last updated: